JACQUELINE HONEYWILL: Open Payments
NPI 1629796297 · HARRIMAN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,918 in 81 payments from 40 companies in 2025. Trend: 2023 $0 · 2024 $1,326 · 2025 $1,918
Food & beverage: $1,918
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $167 |
| AstraZeneca Pharmaceuticals LP | 5 | $138 |
| Merck Sharp & Dohme LLC | 6 | $135 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Incyte Corporation | 4 | $93 |
| Aveo Pharmaceuticals, Inc. | 2 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| Lilly USA, LLC | 3 | $70 |
| Celgene Corporation | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
Products named: RYBREVANT, KEYTRUDA, FOTIVDA, LIBTAYO, TAGRISSO, JAKAFI, NINLARO, Lenvima.
Industry payments across TN — which companies pay providers there.
